[ET Net News Agency, 8 April 2025] HANSOH PHARMA (03692) rose 3.1% to HK$21.3.
It hits an intra-day high of HK$21.3, breaking above the 20-D SMA of HK$21.188, and an
intra-day low of HK$20.15. The total shares traded was 12.87 million, with a value of
HK$266.43m. The active buy/sell ratio is 68:32, with net buying turnover of HK$89.32m.
GOLDMAN SACHS (ASIA) SEC accounts for greatest net responsive buying turnover of HK$3.96m,
with volume weighted average price of HK$20.727. MERRILL LYNCH FE accounts for greatest
net responsive selling turnover of HK$31.6m, with volume weighted average price of
HK$20.673.
The Hang Seng Index now rose 285 points, or 1.4% to 20,113.

Basic Information
=================

----------------------------------
Nominal 21.300 % Chg +3.15%
High 21.300 Low 20.150
Shares Tr 12.87m Turnover 266.43m
10-D SMA 22.685 %H.V 73.251
20-D SMA 21.188 VWAP 20.700
50-D SMA 19.446 RSI14 51.592
----------------------------------
Status: Breaking above the 20-D SMA, active buy/sell ratio is 68:32, with net buying
turnover of HK$89.32m

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 21.30 +3.15
SIHUAN PHARM (00460) 0.57 +1.79
GRAND PHARMA (00512) 5.72 +2.33
SINO BIOPHARM (01177) 3.41 +2.10
LIVZON PHARMA (01513) 25.50 -0.39
LUYE PHARMA (02186) 1.81 -1.63
FOSUN PHARMA (02196) 13.38 +1.83
SH PHARMA (02607) 10.46 +3.36
CHINARES PHARMA (03320) 4.84 +2.98
ZHAOKE OPHTH-B (06622) 1.43 -2.05
-----------------------------------------------
(ed)